FX006: A NOVEL INTRA-ARTICULAR SUSTAINED-RELEASE STEROID FOR TREATMENT OF OSTEOARTHRITIS PAIN (PHASE II CLINICAL STUDY)

$757,490FY2013Department of the ArmyDOD

Pacira Therapeutics, Inc.

Investigators